RLX Technology Inc. (RLX)
RLX trades on NYSE in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.71
-0.58% on the day
Market cap
$2.1B
Mid cap
Revenue · 2025
$566.1M
+50.3% on 2024
Net income · 2025
$131.8M
23.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | RLX on NYSE |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | Cayman Islands |
| IPO year | 2021 |
| SEC CIK | 0001828365 |
| SEC industry code | Cigarettes |
| Incorporated in | E9 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $566.1M |
| Net income | $131.8M |
| Operating income | $47.0M |
| Net margin | 23.3% |
| Operating margin | 8.3% |
| Revenue growth | +50.3% |
| Cash | $767.5M |
| Total assets | $2.6B |
| P/E (computed) | 15.9× |
| P/S (computed) | 3.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2021-01-22 |
| Latest annual report | 20-F | 2026-04-23 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-08-14 |
Source: SEC EDGAR submissions feed, 88 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.6% |
| 1 month | -0.6% |
| 3 months | -15.3% |
| Year to date | -26.2% |
| 1 year | -27.4% |
| From 52-week high | -33.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TRLV | Trulieve Cannabis Corp. Subordinate Voting Shares | $10.11 | -2.69% | $1.9B |
| CRON | Cronos Group Inc. Common Share | $3.20 | -0.31% | $1.2B |
| RGC | Regencell Bioscience Holdings Limited | $8.19 | +14.87% | $4.1B |
| DFTX | Definium Therapeutics Inc. Common Shares | $34.38 | -2.33% | $4.6B |
| TLRY | Tilray Brands Inc. Common Stock | $3.27 | -2.68% | $483.3M |
| OBIO | Orchestra BioMed Holdings Inc. | $5.72 | -3.21% | $343.8M |
| GLAS | Glass House Brands Inc. Subordinate Voting Shares | $3.85 | -5.64% | $338.8M |
| CGC | Canopy Growth Corporation Common Shares | $0.7625 | +0.66% | $322.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier